Home » ophthalmology contract research organization

Iris Pharma, an ophthalmology contract research organization (CRO) for pre-clinical research in ophthalmology, has announced the completion of its merger with Clirophtha, an ophthalmology contract research organization for clinical studies (Phase I-IV).

An ophthalmology contract research organization with customized solutions

Founded in 1989 by Pierre-Paul Elena, Ph.D., our ophthalmology contract research organization provides drug development services to Biotechnology and Pharmaceutical Industries. It groups three areas of complementary activities using a state-of-the-art apparatus such as Heidelberg Retina Tonograph 2 (HRT2) and digital slit lamp.

Iris Pharma has got an enviable ophthalmology contract research organization background and an exciting specialized research team. Our ophthalmology contract research organization is looking forward to the opportunity to help your company continue its success story in the future.

Our ophthalmology contract research organization provides competence

Thanks to its unique and extensive experience, our ophthalmology contract research organization supplies the necessary understanding and competences to guide your new pharmaceutical drugs through the ocular drug development process.